Utility of Glucagon-Like-Peptide-1-Receptor Agonists in Mast Cell Activation Syndrome, 2025, Lawrence B. Afrin M.D, Blitsheyn et al

[Jonathan Edwards]

Is this a joke at the expense of people who have mcas, or what?

It is intended to reflect the total absurdity of Afrin's claims about 'MCAS'.
It is not that the situation is funny, it is pitiful.